Skip to main content

Table 1 Examination data on presentation and follow-up

From: A case study of a liver transplant-treated patient with glycogen storage disease type Ia presenting with multiple inflammatory hepatic adenomas: an analysis of clinicopathologic and genetic data

Variable

Reference range

First visit

8 Months

(Before transplant)

12 Months

(After transplant)

Height (cm)

–

111

112

113

Weight (kg)

–

19.5

20.5

20

BMI (kg/m2)

18.5–23.9

15.8

16.3

15.7

Glu (mmol/L)

3.90–5.90

2.39

1.83

4.11

LA (mmol/L)

 < 2.10

7.77

11.71

3.88

BA (μmoi/L)

9.0–33.0

60.1

48.4

30.6

PYR (μmoi/L)

30–100

507.8

368.6

82.3

UA (μmoi/L)

160–380

595

574

121

TG (mmoi/L)

0.29–1.83

14.88

14.85

2.15

TCHO (mmoi/L)

2.80–5.70

8.79

8.21

5.11

β-HB (mmoi/L)

0.02–0.27

1.29

2.80

0.12

ALT (IU/L)

 < 40

82

84

19

AST (IU/L)

 < 35

179

160

39

GGT (IU/L)

 < 45

254

333

367

Hepatic adenoma

(min, max(cm))

–

0.6, 3.8

0.9, 4.1

–

  1. Glu glucose, LA lactic acid, BA blood ammonia, PYR pyruvic, UA uric acid, TG triglyceride,TCHO total cholesterol, β-HB β hydroxybutyric acid, ALT alanine transaminase, AST aspartate transaminase, GGT γ-glutamyl transpeptidase, – no data